Tower Research Capital (TRC)’s Vident US Equity Strategy ETF VUSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-1,173
Closed -$30K 5038
2016
Q1
$30K Buy
1,173
+773
+193% +$18.3K ﹤0.01% 1072
2015
Q4
$10K Buy
400
+34
+9% +$867 ﹤0.01% 2154
2015
Q3
$9K Buy
366
+6
+2% +$155 ﹤0.01% 2406
2015
Q2
$10K Buy
360
+219
+155% +$6.04K ﹤0.01% 2717
2015
Q1
$4K Sell
141
-127
-47% -$3.42K ﹤0.01% 3436
2014
Q4
$7K Buy
268
+248
+1,240% +$6.47K ﹤0.01% 2476
2014
Q3
$1K Buy
+20
New +$525 ﹤0.01% 4166

Other funds holding VUSE

Tower Research Capital (TRC)'s VUSE Position: Q2 2016 in Review

Tower Research Capital (TRC) sold out of Vident US Equity Strategy ETF (VUSE) in Q2 2016, closing a stake of 1,173 shares — an estimated $30K sold.

Tower Research Capital (TRC) first reported a position in VUSE in Q3 2014 and held it in 7 quarters. The position peaked at $30K in Q1 2016. 14 funds tracked by Wall St. Rank hold VUSE as of Q2 2016.

  • Tower Research Capital (TRC) reported no remaining Vident US Equity Strategy ETF position as of Q2 2016 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,173 Vident US Equity Strategy ETF shares in Q2 2016, an estimated $30K.
  • Tower Research Capital (TRC) first reported a position in Vident US Equity Strategy ETF in Q3 2014 and held it in 7 quarters.
  • Tower Research Capital (TRC)'s Vident US Equity Strategy ETF position peaked at $30K in Q1 2016.
  • 14 funds tracked by Wall St. Rank held Vident US Equity Strategy ETF as of Q2 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.